AMERANT BAN ($AMTB) posted quarterly earnings results for Q1 2026 on Thursday, April 23rd. The company reported earnings of $0.44 per share, missing estimates of $0.44 by $0.00. The company also reported revenue of $97,660,000, missing estimates of $103,947,180 by $-6,287,180.
You can see Quiver Quantitative's $AMTB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AMERANT BAN Insider Trading Activity
AMERANT BAN insiders have traded $AMTB stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $AMTB stock by insiders over the last 6 months:
- ODILON ALMEIDA purchased 4,816 shares for an estimated $101,083
- CARLOS IAFIGLIOLA (See remarks) purchased 1,000 shares for an estimated $21,739
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AMERANT BAN Hedge Fund Activity
We have seen 72 institutional investors add shares of AMERANT BAN stock to their portfolio, and 60 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 393,537 shares (-89.9%) from their portfolio in Q4 2025, for an estimated $7,677,906
- MALTESE CAPITAL MANAGEMENT LLC removed 374,818 shares (-38.7%) from their portfolio in Q4 2025, for an estimated $7,312,699
- BREVAN HOWARD CAPITAL MANAGEMENT LP added 320,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $6,243,200
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC removed 293,953 shares (-80.8%) from their portfolio in Q4 2025, for an estimated $5,735,023
- KENNEDY CAPITAL MANAGEMENT LLC removed 223,752 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $4,365,401
- BOOTHBAY FUND MANAGEMENT, LLC added 212,879 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,153,269
- VANGUARD GROUP INC added 206,874 shares (+9.3%) to their portfolio in Q4 2025, for an estimated $4,036,111
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AMERANT BAN Analyst Ratings
Wall Street analysts have issued reports on $AMTB in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Raymond James issued a "Outperform" rating on 10/29/2025
- Piper Sandler issued a "Overweight" rating on 10/29/2025
To track analyst ratings and price targets for AMERANT BAN, check out Quiver Quantitative's $AMTB forecast page.
AMERANT BAN Price Targets
Multiple analysts have issued price targets for $AMTB recently. We have seen 3 analysts offer price targets for $AMTB in the last 6 months, with a median target of $23.0.
Here are some recent targets:
- Wood Lay from Keefe, Bruyette & Woods set a target price of $23.0 on 01/28/2026
- Stephen Scouten from Piper Sandler set a target price of $25.0 on 01/26/2026
- Michael Rose from Raymond James set a target price of $23.0 on 01/07/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
